Lyra Therapeutics (LYRA) Short Interest Ratio & Short Volume $0.19 +0.00 (+1.87%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Lyra Therapeutics Short Interest DataLyra Therapeutics (LYRA) has a short interest of 2.10 million shares. This marks a 14.13% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.1, indicating that it would take 1.1 days of the average trading volume of 1.71 million shares to cover all short positions.Current Short Interest2,100,000 sharesPrevious Short Interest1,840,000 sharesChange Vs. Previous Month+14.13%Dollar Volume Sold Short$433,440.00Short Interest Ratio1.1 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares65,460,000 sharesPercentage of Shares Shorted3.21%Today's Trading Volume440,851 sharesAverage Trading Volume1,709,420 sharesToday's Volume Vs. Average26% Short Selling Lyra Therapeutics? Sign up to receive the latest short interest report for Lyra Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLYRA Short Interest Over TimeLYRA Days to Cover Over TimeLYRA Percentage of Float Shorted Over Time Lyra Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/20242,100,000 shares $433,440.00 +14.1%N/A1.1 $0.21 12/15/20241,840,000 shares $335,984.00 -16.4%N/A1.1 $0.18 11/30/20242,200,000 shares $455,400.00 -7.6%N/A1.4 $0.21 11/15/20242,380,000 shares $404,600.00 +16.7%N/A1.6 $0.17 10/31/20242,040,000 shares $560,796.00 -4.7%N/A2.1 $0.27 10/15/20242,140,000 shares $488,776.00 -24.9%N/A2.2 $0.23 9/30/20242,850,000 shares $732,450.00 -9.2%N/A3.2 $0.26 9/15/20243,140,000 shares $879,200.00 +6.1%N/A2.7 $0.28 8/31/20242,960,000 shares $952,232.00 -28.7%N/A2.3 $0.32 8/15/20244,150,000 shares $1.20 million +18.6%N/A2.7 $0.29 Get the Latest News and Ratings for LYRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lyra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/20243,500,000 shares $1.14 million -5.9%N/A1.7 $0.33 7/15/20243,720,000 shares $1.13 million +86.9%N/A1 $0.31 6/30/20241,990,000 shares $550,633.00 +28.4%N/A0.5 $0.28 6/15/20241,550,000 shares $457,560.00 +71.8%N/A0.4 $0.30 5/31/2024902,200 shares $295,921.60 +49.6%N/A0.3 $0.33 5/15/2024603,000 shares $214,547.40 +45.7%N/A0.2 $0.36 4/30/2024413,800 shares $2.14 million +24.0%N/A0.2 $5.16 4/15/2024333,600 shares $1.76 million +49.6%N/A1 $5.27 3/31/2024223,000 shares $1.39 million +8.1%N/A0.7 $6.22 3/15/2024206,300 shares $1.22 million +28.8%N/A0.8 $5.93 2/29/2024160,200 shares $842,652.00 -13.6%N/A0.6 $5.26 2/15/2024185,400 shares $927,000.00 +43.5%N/A0.8 $5.00 1/31/2024129,200 shares $587,860.00 -5.6%N/A0.6 $4.55 1/15/2024136,900 shares $736,522.00 -22.6%N/A0.6 $5.38 12/31/2023176,800 shares $926,432.00 +2.4%N/A0.9 $5.24 12/15/2023172,600 shares $802,590.00 -24.4%N/A0.7 $4.65 11/30/2023228,300 shares $755,673.00 -13.9%N/A0.6 $3.31 11/15/2023265,200 shares $766,428.00 -17.3%N/A0.7 $2.89 10/31/2023320,600 shares $952,182.00 +43.2%N/A0.9 $2.97 10/15/2023223,900 shares $801,562.00 -38.2%N/A0.6 $3.58 9/30/2023362,100 shares $1.42 million -14.0%N/A0.9 $3.91 9/15/2023421,100 shares $1.83 million +661.5%N/A1.2 $4.35 8/31/202355,300 shares $192,444.00 -19.5%N/A0.3 $3.48 8/15/202368,700 shares $245,946.00 -67.0%N/A0.4 $3.58 7/31/2023208,100 shares $670,082.00 -62.3%N/A1.1 $3.22 7/15/2023552,200 shares $1.69 million -0.1%N/A3.4 $3.06 6/30/2023552,600 shares $2.27 million +23.4%N/A4.2 $4.11 6/15/2023447,700 shares $1.34 million +56.8%N/A3.9 $2.99 5/31/2023285,500 shares $733,735.00 +1,513.0%N/A3.7 $2.57 5/15/202317,700 shares $46,197.00 -31.4%N/A0.5 $2.61Wall St turns to THIS catalyst after Trump’s inauguration (Ad)Wall Street is already looking past Trump… To a new catalyst on the near horizon that could be even bigger than his inauguration. As soon as January 29th…So please watch this video now before the hammer falls and it’s too late. 4/30/202325,800 shares $61,920.00 +27.1%N/A0.7 $2.40 4/15/202320,300 shares $48,517.00 +178.1%N/A0.6 $2.39 3/31/20237,300 shares $14,673.00 -29.1%N/A0.2 $2.01 3/15/202310,300 shares $21,012.00 -32.2%N/A0.3 $2.04 2/28/202315,200 shares $36,176.00 +22.6%N/A0.5 $2.38 2/15/202312,400 shares $30,256.00 +21.6%N/A0.4 $2.44 1/31/202310,200 shares $29,070.00 -21.5%N/A0.3 $2.85 1/15/202313,000 shares $36,010.00 -29.7%N/A0.2 $2.77 12/30/202218,500 shares $58,090.00 +44.5%N/A0.3 $3.14 12/15/202212,800 shares $34,944.00 -41.6%N/A0.2 $2.73 11/30/202221,900 shares $76,869.00 +0.5%N/A0.3 $3.51 11/15/202221,800 shares $85,020.00 No ChangeN/A0.3 $3.90 10/31/202221,800 shares $102,242.00 -27.6%N/A0.3 $4.69 10/15/202230,100 shares $144,480.00 -16.4%N/A0.9 $4.80 9/30/202236,000 shares $180,360.00 -45.4%N/A1 $5.01 9/15/202265,900 shares $392,764.00 -25.5%N/A1.6 $5.96 8/31/202288,400 shares $511,836.00 -18.8%N/A1.4 $5.79 8/15/2022108,800 shares $683,264.00 -22.6%N/A1.6 $6.28 7/31/2022140,600 shares $912,494.00 -44.2%N/A1.9 $6.49 7/15/2022252,000 shares $1.43 million -17.5%N/A2.7 $5.69 6/30/2022305,300 shares $1.72 million +13.6%N/A1.2 $5.65 6/15/2022268,700 shares $1.35 million -38.5%N/A1 $5.02 5/31/2022437,000 shares $2.34 million +5.1%N/A1.9 $5.35 5/15/2022415,800 shares $2.03 million +10.7%N/A1.8 $4.88 4/30/2022375,600 shares $2.12 million +50.0%N/A1.7 $5.65 4/15/2022250,400 shares $1.88 million +224.4%3.9%1.2 $7.51 3/31/202277,200 shares $310,344.00 +19.0%0.9%0.5 $4.02 3/15/202264,900 shares $262,845.00 -44.8%0.7%1.5 $4.05 2/28/2022117,500 shares $572,225.00 +36.3%1.2%2.4 $4.87 2/15/202286,200 shares $387,900.00 +9.1%0.9%1.6 $4.50 1/31/202279,000 shares $323,110.00 +5.6%0.8%1.3 $4.09 1/15/202274,800 shares $295,460.00 +4.0%0.8%1.2 $3.95 12/31/202171,900 shares $313,484.00 -5.8%0.8%1.2 $4.36 12/15/202176,300 shares $334,194.00 -1.0%0.8%1.4 $4.38 11/30/202177,100 shares $431,760.00 +2.5%0.8%1.4 $5.60 11/15/202175,200 shares $539,936.00 -51.4%0.9%1.5 $7.18 10/29/2021154,600 shares $1.13 million -3.6%1.8%3.3 $7.30 10/15/2021160,400 shares $1.26 million -20.9%1.9%3.4 $7.85 9/30/2021202,700 shares $1.85 million -0.3%2.3%4.2 $9.12 9/15/2021203,300 shares $1.68 million -3.1%2.4%2.9 $8.28 8/31/2021209,700 shares $1.50 million -11.0%2.4%2.5 $7.14 8/13/2021235,700 shares $1.64 million +1.3%2.7%2.1 $6.94 7/30/2021232,700 shares $1.50 million -2.8%2.7%1.9 $6.44 7/15/2021239,400 shares $1.78 million +0.3%2.8%1.9 $7.45 6/30/2021238,700 shares $1.92 million -43.6%2.8%1.8 $8.03 6/15/2021423,100 shares $3.88 million +17.9%4.9%3.6 $9.17 5/28/2021358,900 shares $2.58 million -13.2%4.1%3.4 $7.18 5/14/2021413,600 shares $3.09 million +14.1%4.8%4.6 $7.46 4/30/2021362,500 shares $3.69 million +10.9%4.4%2.4 $10.18 4/15/2021327,000 shares $3.56 million +4.1%3.9%2.1 $10.89Wall St turns to THIS catalyst after Trump’s inauguration (Ad)Wall Street is already looking past Trump… To a new catalyst on the near horizon that could be even bigger than his inauguration. As soon as January 29th…So please watch this video now before the hammer falls and it’s too late. 3/31/2021314,200 shares $3.51 million +11.3%3.8%2.1 $11.17 3/15/2021282,300 shares $3.95 million +15.4%3.4%1.8 $13.98 2/26/2021244,600 shares $3.42 million +73.6%3.1%1.3 $14.00 2/12/2021140,900 shares $1.86 million -1.4%1.8%0.7 $13.19 1/29/2021142,900 shares $1.53 million +9.3%1.8%1.1 $10.68 1/15/2021130,800 shares $1.43 million No Change1.6%1.1 $10.96 LYRA Short Interest - Frequently Asked Questions What is Lyra Therapeutics' current short interest? Short interest is the volume of Lyra Therapeutics shares that have been sold short but have not yet been closed out or covered. As of December 31st, investors have sold 2,100,000 shares of LYRA short. Learn More on Lyra Therapeutics' current short interest. What is a good short interest ratio for Lyra Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LYRA shares currently have a short interest ratio of 1.0. Learn More on Lyra Therapeutics's short interest ratio. Is Lyra Therapeutics' short interest increasing or decreasing? Lyra Therapeutics saw a increase in short interest in December. As of December 31st, there was short interest totaling 2,100,000 shares, an increase of 14.1% from the previous total of 1,840,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Lyra Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "medical equipment" compare to Lyra Therapeutics: iCAD, Inc. (0.86%), Inovio Pharmaceuticals, Inc. (12.16%), Lucid Diagnostics Inc. (1.78%), Nutriband Inc. (1.60%), Modular Medical, Inc. (1.01%), CollPlant Biotechnologies Ltd. (0.08%), Outset Medical, Inc. (4.68%), Daxor Co. (0.45%), Microbot Medical Inc. (5.14%), Spectral AI, Inc. (12.63%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Lyra Therapeutics stock? Short selling LYRA is an investing strategy that aims to generate trading profit from Lyra Therapeutics as its price is falling. LYRA shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lyra Therapeutics? A short squeeze for Lyra Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LYRA, which in turn drives the price of the stock up even further. How often is Lyra Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LYRA, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies iCAD Short Interest Data Inovio Pharmaceuticals Short Interest Data Lucid Diagnostics Short Interest Data Nutriband Short Interest Data Modular Medical Short Interest Data CollPlant Biotechnologies Short Interest Data Outset Medical Short Interest Data Daxor Short Interest Data Microbot Medical Short Interest Data Spectral AI Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LYRA) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LYRA Stock Alerts